Lupin Receives FDA Approval for Generic Ortho Tri-cyclen Lo

News | 03 July 2012

MUMBAI and BALTIMORE, July 3, 2012 /PRNewswire/ -- BSE : 500257 NSE: Lupin REUTERS: LUPN.BO BLOOMBERG: LPC IN Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received ...

Click on the link to read the full article at Healthcare Global (press release)
(This link will open in a new window)